Poon KKS, Wong SHS. New and developing anesthesia drugs. Expert Opin Pharmacother. 2017;18(2):195–204.
Article CAS PubMed Google Scholar
Kim H, Park S-S, Shim J. Differences in midazolam premedication effects on recovery after short-duration ambulatory anesthesia with propofol or sevoflurane for gynecologic surgery in young patients: a randomized controlled trial. Medicine (Baltimore). 2020;99(47):e23194.
Article CAS PubMed Google Scholar
Ong LB, Plummer JL, Waldow WC, Owen H. Timing of midazolam and propofol administration for co-induction of anaesthesia. Anaesth Intensive Care. 2000;28(5):527–31.
Article CAS PubMed Google Scholar
Nordt SP, Clark RF. Midazolam: a review of therapeutic uses and toxicity. J Emerg Med. 1997;15(3):357–65.
Article CAS PubMed Google Scholar
Perel A. Non-anaesthesiologists should not be allowed to administer propofol for procedural sedation: a consensus statement of 21 European National Societies of Anaesthesia. Eur J Anaesthesiol. 2011;28(8):580–4.
Hemphill S, McMenamin L, Bellamy MC, Hopkins PM. Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth. 2019;122(4):448–59.
Article CAS PubMed PubMed Central Google Scholar
Keam SJ. Remimazolam: first approval. Drugs. 2020;80(6):625–33.
Kilpatrick GJ. Remimazolam: non-clinical and clinical profile of a new sedative/anesthetic agent. Front Pharmacol. 2021;12:690875.
Article CAS PubMed PubMed Central Google Scholar
Goudra BG, Singh PM. Remimazolam: the future of its sedative potential. Saudi J Anaesth. 2014;8(3):388–91.
Article PubMed PubMed Central Google Scholar
Noor N, Legendre R, Cloutet A, Chitneni A, Varrassi G, Kaye AD. A comprehensive review of remimazolam for sedation. Health Psychol Res. 2021;9(1):24514.
Article PubMed PubMed Central Google Scholar
Lee A, Shirley M. Remimazolam: a review in procedural sedation. Drugs. 2021;81(10):1193–201.
Article CAS PubMed Google Scholar
Higgins JPT, Altman DG, Gøtzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Article PubMed PubMed Central Google Scholar
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–5.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
Article PubMed PubMed Central Google Scholar
Choi JY, Lee HS, Kim JY, et al. Comparison of remimazolam-based and propofol-based total intravenous anesthesia on postoperative quality of recovery: a randomized non-inferiority trial. J Clin Anesth. 2022;82:110955.
Article CAS PubMed Google Scholar
Dai G, Pei L, Duan F, et al. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia. Minerva Anestesiol. 2021;87(10):1073–9.
Doi M, Morita K, Takeda J, et al. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34(4):543–53.
Jeon Y-G, Kim S, Park J-H, et al. Incidence of intraoperative hypotension in older patients undergoing total intravenous anesthesia by remimazolam versus propofol: a randomized controlled trial. Medicine (Baltimore). 2023;102(49): e36440.
Article CAS PubMed Google Scholar
Kuang Q, Zhong N, Ye C, Zhu X, Wei F. Propofol versus remimazolam on cognitive function, hemodynamics, and oxygenation during one-lung ventilation in older patients undergoing pulmonary lobectomy: a randomized controlled trial. J Cardiothorac Vasc Anesth. 2023;37(10):1996–2005.
Article CAS PubMed Google Scholar
Liu T, Lai T, Chen J, et al. Effect of remimazolam induction on hemodynamics in patients undergoing valve replacement surgery: a randomized, double-blind, controlled trial. Pharmacol Res Perspect. 2021;9(5):e00851.
Article CAS PubMed PubMed Central Google Scholar
Sun WLM, Wan J, et al. Efficacy and safety of remimazolam tosilate versus propofol in patients undergoing day surgery: a prospective randomized controlled trial. BMC Anesthesiol. 2023;23(1):182.
Article PubMed PubMed Central Google Scholar
Mao Y, Guo J, Yuan J, Zhao E, Yang J. Quality of recovery after general anesthesia with remimazolam in patients’ undergoing urologic surgery: a randomized controlled trial comparing remimazolam with propofol. Drug Des DevelTher. 2022;27(16):1199–209.
Matsumoto A, Satomi S, Kakuta N, et al. Remimazolam’s effects on postoperative nausea and vomiting are similar to those of propofol after laparoscopic gynecological surgery: a randomized controlled trial. J Clin Med. 2023;12(16):5402.
Article CAS PubMed PubMed Central Google Scholar
Oh EJ, Chung YJ, Lee J-H, et al. Comparison of propofol vs remimazolam on emergence profiles after general anesthesia: a randomized clinical trial. J Clin Anesth. 2023;90:111223.
Article CAS PubMed Google Scholar
Sato T, Nishiwaki K. Comparison of remimazolam and propofol in anesthetic management for awake craniotomy: a retrospective study. J Anesth. 2022;36(1):152–5.
Shi Fu, Chen Y, Li H, Zhang Y, Zhao T. Efficacy and safety of remimazolam tosilate versus propofol for general anesthesia in cirrhotic patients undergoing endoscopic variceal ligation. Int J Gen Med. 2022;13(15):583–91.
Tang F, Yi J-M, Gong H-Y, et al. Remimazolam benzenesulfonate anesthesia effectiveness in cardiac surgery patients under general anesthesia. World J Clin Cases. 2021;9(34):10595–603.
Article PubMed PubMed Central Google Scholar
Tang L, Sun Y, Hao X, et al. Effect of general anaesthesia with remimazolam versus propofol on postoperative quality of recovery in patients undergoing ambulatory arthroscopic meniscus repair: a randomised clinical trial. BJA Open. 2023;28(8):100237.
Yue L, Ma X, Li Na, et al. Remimazolam versus propofol in combination with esketamine for surgical abortion: a double-blind randomized controlled trial. Clin Transl Sci. 2023;16(9):1606–16.
Article CAS PubMed PubMed Central Google Scholar
Zhang J, Wang X, Zhang Q, Wang Z, Zhu S. Application effects of remimazolam and propofol on elderly patients undergoing hip replacement. BMC Anesthesiol. 2022;22(1):118.
Article CAS PubMed PubMed Central Google Scholar
Zhu X, Wang H, Yuan S, et al. Efficacy and safety of remimazolam in endoscopic sedation-a systematic review and meta-analysis. Front Med (Lausanne). 2021;8:655042.
Xueyan Wu, Wang C, Gao H, et al. Comparison of remimazolam and propofol about safety outcome indicators during general anesthesia in surgical patients: a systematic review and meta-analysis. Minerva Anestesiol. 2023;89(6):553–64.
Bo-JyunJhuang B-H, Huang Y-T, Lai P-C. Efficacy and safety of remimazolam for procedural sedation: a meta-analysis of randomized controlled trials with trial sequential analysis. Front Med (Lausanne). 2021;27(8):641866.
Zhang S, Wang J, Ran R, Peng Y, Xiao Y. Efficacy and safety of remimazolam tosylate in hysteroscopy: a randomized, single-blind, parallel controlled trial. J Clin Pharm Ther. 2022;47(1):55–60.
Article CAS PubMed Google Scholar
Zhang X, Li S, Liu J. Efficacy and safety of remimazolam besylate versus propofol during hysteroscopy: single-centre randomized controlled trial. BMC Anesthesiol. 2021;21(1):156.
Article CAS PubMed PubMed Central Google Scholar
Liu X, Ding B, Shi F, et al. The efficacy and safety of remimazolam tosilate versus etomidate-propofol in elderly outpatients undergoing colonoscopy: a prospective, randomized, single-blind, non-inferiority trial. Drug Des Devel Ther. 2021;15:4675–85.
Article CAS PubMed PubMed Central Google Scholar
Chen S, Wang J, Xu X, et al. The efficacy and safety of remimazolam tosylate versus propofol in patients undergoing colonoscopy: a multicentered, randomized, positive-controlled, phase III clinical trial. Am J Transl Res. 2020;12(8):4594–603.
CAS PubMed PubMed Central Google Scholar
Toyota Y, Kondo T, Oshita K, et al. Remimazolam-based anesthesia with flumazenil allows faster emergence than propofol-based anesthesia in older patients undergoing spinal surgery: a randomized controlled trial. Medicine (Baltimore). 2023;102(46):e36081.
Comments (0)